Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
- Author
- RUDIN, Charles M1 ; HANN, Christine L1 ; RANSON, Malcolm R11 ; DIVE, Caroline12 ; MCKEEGAN, Evelyn M6 ; CHYLA, Brenda J6 ; DOWELL, Barry L6 ; CHAKRAVARTTY, Arunava6 ; NOLAN, Cathy E6 ; RUDERSDORF, Niki6 ; BUSMAN, Todd A6 ; MABRY, Mack H6 ; GARON, Edward B3 ; KRIVOSHIK, Andrew P6 ; HUMERICKHOUSE, Rod A6 ; SHAPIRO, Geoffrey I13 ; GANDHI, Leena13 ; DE OLIVEIRA, Moacyr Ribeiro4 ; BONOMI, Philip D5 ; ROSS CAMIDGE, D7 ; CHU, Quincy8 ; GIACCONE, Giuseppe2 ; KHAIRA, Divis9 ; RAMALINGAM, Suresh S10
[1] Johns Hopkins University, United States
[2] National Cancer Institute, Baltimore, Maryland, United States
[3] University of California Los Angeles, Los Angeles, California, United States
[4] Northwest Medical Specialties, PLLC, Tacoma, Washington, United States
[5] Rush University Medical Center, United States
[6] Abbott Laboratories, Chicago, Illinois, United States
[7] UC Davis Cancer Center, Sacramento, California, United States
[8] Cross Cancer Institute, University of Alberta/Alberta Health Services, Alberta, Canada
[9] Sunterra Oncology Associates, Phoenix, Arizona, United States
[10] Winship Cancer Institute of Emory University, Atlanta, Georgia
[11] The Christie NHS Foundation Trust, United States
[12] Paterson Institute for Cancer Research, University of Manchester, Manchester, United Kingdom
[13] Dana-Farber Cancer Institute, Boston, Massachusetts, United States - Source
Clinical cancer research (Print). 2012, Vol 18, Num 11, pp 3163-3169, 7 p ; ref : 43 ref
- CODEN
- CCREF4
- ISSN
- 1078-0432
- Scientific domain
- Medical oncology; Pharmacology drugs
- Publisher
- American Association for Cancer Research, Philadelphia, PA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Cancer du poumon Carcinome à petites cellules bronchopulmonaire Essai clinique phase II Homme Malade Marqueur biologique Récidive Traitement Cancer Pathologie de l'appareil respiratoire Pathologie des bronches Pathologie des poumons Tumeur maligne
- Keyword (en)
- Lung cancer Bonchopulmonary small cell carcinoma Phase II trial Human Patient Biological marker Relapse Treatment Cancer Respiratory disease Bronchus disease Lung disease Malignant tumor
- Keyword (es)
- Cáncer del pulmón Carcinoma pequeňa célula bronchopulmonar Ensayo clínico fase II Hombre Enfermo Marcador biológico Recaida Tratamiento Cáncer Aparato respiratorio patología Bronquio patología Pulmón patología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B11 Pneumology / 002B11A Tumors of the respiratory system and mediastinum
- Discipline
- Pharmacological treatments Pulmonology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 25944967
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1158/1078-0432.CCR-11-3090 
https://dx.doi.org/10.1158/1078-0432.CCR-11-3090
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/1078-0432.CCR-11-3090\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer\";s:9:\"\u0000*\u0000jtitle\";s:32:\"Clinical cancer research (Print)\";s:9:\"\u0000*\u0000stitle\";s:25:\"Clin. cancer res. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"18\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"3163\";s:8:\"\u0000*\u0000epage\";s:4:\"3169\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"RUDIN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Charles M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:23:{i:0;s:17:\"HANN, Christine L\";i:1;s:17:\"RANSON, Malcolm R\";i:2;s:14:\"DIVE, Caroline\";i:3;s:18:\"MCKEEGAN, Evelyn M\";i:4;s:15:\"CHYLA, Brenda J\";i:5;s:15:\"DOWELL, Barry L\";i:6;s:21:\"CHAKRAVARTTY, Arunava\";i:7;s:14:\"NOLAN, Cathy E\";i:8;s:16:\"RUDERSDORF, Niki\";i:9;s:14:\"BUSMAN, Todd A\";i:10;s:13:\"MABRY, Mack H\";i:11;s:15:\"GARON, Edward B\";i:12;s:19:\"KRIVOSHIK, Andrew P\";i:13;s:20:\"HUMERICKHOUSE, Rod A\";i:14;s:19:\"SHAPIRO, Geoffrey I\";i:15;s:13:\"GANDHI, Leena\";i:16;s:27:\"DE OLIVEIRA, Moacyr Ribeiro\";i:17;s:16:\"BONOMI, Philip D\";i:18;s:15:\"ROSS CAMIDGE, D\";i:19;s:11:\"CHU, Quincy\";i:20;s:18:\"GIACCONE, Giuseppe\";i:21;s:13:\"KHAIRA, Divis\";i:22;s:20:\"RAMALINGAM, Suresh S\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CCREF4\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/1078-0432.CCR-11-3090\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer\";s:9:\"\u0000*\u0000jtitle\";s:32:\"Clinical cancer research (Print)\";s:9:\"\u0000*\u0000stitle\";s:25:\"Clin. cancer res. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"18\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"3163\";s:8:\"\u0000*\u0000epage\";s:4:\"3169\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"RUDIN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Charles M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:23:{i:0;s:17:\"HANN, Christine L\";i:1;s:17:\"RANSON, Malcolm R\";i:2;s:14:\"DIVE, Caroline\";i:3;s:18:\"MCKEEGAN, Evelyn M\";i:4;s:15:\"CHYLA, Brenda J\";i:5;s:15:\"DOWELL, Barry L\";i:6;s:21:\"CHAKRAVARTTY, Arunava\";i:7;s:14:\"NOLAN, Cathy E\";i:8;s:16:\"RUDERSDORF, Niki\";i:9;s:14:\"BUSMAN, Todd A\";i:10;s:13:\"MABRY, Mack H\";i:11;s:15:\"GARON, Edward B\";i:12;s:19:\"KRIVOSHIK, Andrew P\";i:13;s:20:\"HUMERICKHOUSE, Rod A\";i:14;s:19:\"SHAPIRO, Geoffrey I\";i:15;s:13:\"GANDHI, Leena\";i:16;s:27:\"DE OLIVEIRA, Moacyr Ribeiro\";i:17;s:16:\"BONOMI, Philip D\";i:18;s:15:\"ROSS CAMIDGE, D\";i:19;s:11:\"CHU, Quincy\";i:20;s:18:\"GIACCONE, Giuseppe\";i:21;s:13:\"KHAIRA, Divis\";i:22;s:20:\"RAMALINGAM, Suresh S\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CCREF4\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/1078-0432.CCR-11-3090\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/1078-0432.CCR-11-3090\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer\";s:9:\"\u0000*\u0000jtitle\";s:32:\"Clinical cancer research (Print)\";s:9:\"\u0000*\u0000stitle\";s:25:\"Clin. cancer res. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"18\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"3163\";s:8:\"\u0000*\u0000epage\";s:4:\"3169\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"RUDIN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Charles M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:23:{i:0;s:17:\"HANN, Christine L\";i:1;s:17:\"RANSON, Malcolm R\";i:2;s:14:\"DIVE, Caroline\";i:3;s:18:\"MCKEEGAN, Evelyn M\";i:4;s:15:\"CHYLA, Brenda J\";i:5;s:15:\"DOWELL, Barry L\";i:6;s:21:\"CHAKRAVARTTY, Arunava\";i:7;s:14:\"NOLAN, Cathy E\";i:8;s:16:\"RUDERSDORF, Niki\";i:9;s:14:\"BUSMAN, Todd A\";i:10;s:13:\"MABRY, Mack H\";i:11;s:15:\"GARON, Edward B\";i:12;s:19:\"KRIVOSHIK, Andrew P\";i:13;s:20:\"HUMERICKHOUSE, Rod A\";i:14;s:19:\"SHAPIRO, Geoffrey I\";i:15;s:13:\"GANDHI, Leena\";i:16;s:27:\"DE OLIVEIRA, Moacyr Ribeiro\";i:17;s:16:\"BONOMI, Philip D\";i:18;s:15:\"ROSS CAMIDGE, D\";i:19;s:11:\"CHU, Quincy\";i:20;s:18:\"GIACCONE, Giuseppe\";i:21;s:13:\"KHAIRA, Divis\";i:22;s:20:\"RAMALINGAM, Suresh S\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CCREF4\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/1078-0432.CCR-11-3090\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer\";s:9:\"\u0000*\u0000jtitle\";s:32:\"Clinical cancer research (Print)\";s:9:\"\u0000*\u0000stitle\";s:25:\"Clin. cancer res. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"18\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"3163\";s:8:\"\u0000*\u0000epage\";s:4:\"3169\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"RUDIN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Charles M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:23:{i:0;s:17:\"HANN, Christine L\";i:1;s:17:\"RANSON, Malcolm R\";i:2;s:14:\"DIVE, Caroline\";i:3;s:18:\"MCKEEGAN, Evelyn M\";i:4;s:15:\"CHYLA, Brenda J\";i:5;s:15:\"DOWELL, Barry L\";i:6;s:21:\"CHAKRAVARTTY, Arunava\";i:7;s:14:\"NOLAN, Cathy E\";i:8;s:16:\"RUDERSDORF, Niki\";i:9;s:14:\"BUSMAN, Todd A\";i:10;s:13:\"MABRY, Mack H\";i:11;s:15:\"GARON, Edward B\";i:12;s:19:\"KRIVOSHIK, Andrew P\";i:13;s:20:\"HUMERICKHOUSE, Rod A\";i:14;s:19:\"SHAPIRO, Geoffrey I\";i:15;s:13:\"GANDHI, Leena\";i:16;s:27:\"DE OLIVEIRA, Moacyr Ribeiro\";i:17;s:16:\"BONOMI, Philip D\";i:18;s:15:\"ROSS CAMIDGE, D\";i:19;s:11:\"CHU, Quincy\";i:20;s:18:\"GIACCONE, Giuseppe\";i:21;s:13:\"KHAIRA, Divis\";i:22;s:20:\"RAMALINGAM, Suresh S\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CCREF4\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/1078-0432.CCR-11-3090\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer\";s:9:\"\u0000*\u0000jtitle\";s:32:\"Clinical cancer research (Print)\";s:9:\"\u0000*\u0000stitle\";s:25:\"Clin. cancer res. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"18\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"3163\";s:8:\"\u0000*\u0000epage\";s:4:\"3169\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"RUDIN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Charles M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:23:{i:0;s:17:\"HANN, Christine L\";i:1;s:17:\"RANSON, Malcolm R\";i:2;s:14:\"DIVE, Caroline\";i:3;s:18:\"MCKEEGAN, Evelyn M\";i:4;s:15:\"CHYLA, Brenda J\";i:5;s:15:\"DOWELL, Barry L\";i:6;s:21:\"CHAKRAVARTTY, Arunava\";i:7;s:14:\"NOLAN, Cathy E\";i:8;s:16:\"RUDERSDORF, Niki\";i:9;s:14:\"BUSMAN, Todd A\";i:10;s:13:\"MABRY, Mack H\";i:11;s:15:\"GARON, Edward B\";i:12;s:19:\"KRIVOSHIK, Andrew P\";i:13;s:20:\"HUMERICKHOUSE, Rod A\";i:14;s:19:\"SHAPIRO, Geoffrey I\";i:15;s:13:\"GANDHI, Leena\";i:16;s:27:\"DE OLIVEIRA, Moacyr Ribeiro\";i:17;s:16:\"BONOMI, Philip D\";i:18;s:15:\"ROSS CAMIDGE, D\";i:19;s:11:\"CHU, Quincy\";i:20;s:18:\"GIACCONE, Giuseppe\";i:21;s:13:\"KHAIRA, Divis\";i:22;s:20:\"RAMALINGAM, Suresh S\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CCREF4\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
